KR880005945A - 전신 약품의 경피 투여용 침투 증강제 - Google Patents

전신 약품의 경피 투여용 침투 증강제 Download PDF

Info

Publication number
KR880005945A
KR880005945A KR870012976A KR870012976A KR880005945A KR 880005945 A KR880005945 A KR 880005945A KR 870012976 A KR870012976 A KR 870012976A KR 870012976 A KR870012976 A KR 870012976A KR 880005945 A KR880005945 A KR 880005945A
Authority
KR
South Korea
Prior art keywords
carbon atoms
drug
group
effective
systemically
Prior art date
Application number
KR870012976A
Other languages
English (en)
Inventor
브이.펙 제임스
미내스카니언 게볼크
Original Assignee
케네쓰 이.이킨스
넬슨 리써취 앤드 디벨럽먼트 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 케네쓰 이.이킨스, 넬슨 리써취 앤드 디벨럽먼트 캄파니 filed Critical 케네쓰 이.이킨스
Publication of KR880005945A publication Critical patent/KR880005945A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
    • D06M13/322—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
    • D06M13/402—Amides imides, sulfamic acids
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06P—DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
    • D06P1/00—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed
    • D06P1/44—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using insoluble pigments or auxiliary substances, e.g. binders
    • D06P1/64—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using insoluble pigments or auxiliary substances, e.g. binders using compositions containing low-molecular-weight organic compounds without sulfate or sulfonate groups
    • D06P1/642—Compounds containing nitrogen
    • D06P1/649—Compounds containing carbonamide, thiocarbonamide or guanyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Textile Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음

Description

전신 약품의 경피 투여용 침투 증강제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

1. 하기 일반식을 갖는 막 침투 증강제 유효량을 국소 투여하는 점이 개선된, 전신에 유효한 약품을 경피 투여용 장치 또는 제제물로 인체 및 동물의 피부 또는 점막을 통하여 국소 투여하는 방법.
상기 식중, R¹및 R²는 1-20개, 적합하기로는 2-14개의 탄소원자로 구성된 알킬기 및 시클로알킬기로 되는 군 중에서 독립적으로 선택된 것이고, R은 1-30개, 적합하기로는 1-20개의 탄소원자로 구성된 알킬기 및 시클로알킬기로 되는 군 중에서 선택된 것이되 단, 상기 화합물 중의 탄소원자 총 수는 15개 이상이며, R¹과 R²중의 탄소원자 총 수는 5개 이상이다.
제1항에 있어서, R¹및 R²가 1-20개의 탄소원자로 구성된 알킬 및 시클로알킬기로 되는 군 중에서 독립적으로 선택된 것인 방법.
제2항에 있어서, R¹및 R²기 3-12개의 탄소원자를 가진 노르말 알킬기 또는 시클로알킬기인 방법.
제3항에 있어서, R이 구조식 - (CH₂)nCH₃(여기서, n은 정수 0-19임)으로 표시되는 것인 방법.
제4항에 있어서, n이 0 또는 10인 방법.
제1항에 있어서. 전신에 유효한 약품이 치료 약품인 방법.
제6항에 있어서, 투여가 동시에 일어나는 방법.
제1항에 있어서 , 막 침투 증강제가 N-n-부틸, N-n-도데실아세트아미드, N, N-디 -n-도데실 아세트아미드, N-시클로헵틸, -N-n-도데실아세트아미드 및 N,N-n-디 -n-프로필도데칸아미드로 되는 군 중에서 선택된 것인 방법.
제1항에 있어서, 전신에 유효한 약품이 할로페리돌, 이소소르바이드 디나이트레이트, 니트로글리세린, 에스트라디올, 클로니딘, 프로프라놀올, 인도메타신, 니페디핀, 니카르디핀, 디클로로페낙 및 메타프로테레놀로 되는 군 중에서 선택되는 것인 방법.
제8항에 있어서, 전신에 유효한 약품 할로페리돌, 이소소르바이드 디나이트레이트, 니트로글리세린, 에스트라디올, 클로니딘. 프로프라놀올, 인도메타신, 니페디핀, 니카르디핀, 디클로로페낙 및 메타프로 테레놀로 되는 군 중에서 선택되는 것인 방법.
※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR870012976A 1986-11-19 1987-11-18 전신 약품의 경피 투여용 침투 증강제 KR880005945A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/932,651 US4808414A (en) 1986-09-29 1986-11-19 Amide penetration enhancers for transdermal delivery of systemic agents
US932651 1992-08-20

Publications (1)

Publication Number Publication Date
KR880005945A true KR880005945A (ko) 1988-07-21

Family

ID=25462662

Family Applications (1)

Application Number Title Priority Date Filing Date
KR870012976A KR880005945A (ko) 1986-11-19 1987-11-18 전신 약품의 경피 투여용 침투 증강제

Country Status (9)

Country Link
US (1) US4808414A (ko)
EP (1) EP0268220B1 (ko)
JP (1) JPS63139136A (ko)
KR (1) KR880005945A (ko)
AT (1) ATE76303T1 (ko)
AU (1) AU624573B2 (ko)
DE (1) DE3779260D1 (ko)
ES (1) ES2042528T3 (ko)
GR (1) GR3005442T3 (ko)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973579A (en) * 1985-06-28 1990-11-27 Merck & Co., Inc. Enhancment of absorption of drugs from gastrointestinal tract using choline ester salts
US4902676A (en) * 1986-09-29 1990-02-20 Nelson Research & Development Co. Compositions comprising N,N-dialkylalkanamides
ES2038154T3 (es) * 1986-11-19 1993-07-16 Whitby Research, Inc. Un procedimiento para preparar una composicion para potenciar la penetracion de membranas de al menos un agente sistematicamente activo.
US5234959A (en) * 1988-04-08 1993-08-10 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US5472946A (en) * 1988-04-08 1995-12-05 Peck; James V. Transdermal penetration enhancers
US4927626A (en) * 1988-10-28 1990-05-22 Devillez Richard L Method for enhancement of unguis growth
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
AU6712090A (en) * 1989-10-13 1991-05-16 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
US5705185A (en) * 1991-09-25 1998-01-06 Beta Pharmaceuticals Co. Transdermal delivery of estradiol and process for manufacturing said device
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
NZ244862A (en) * 1991-10-23 1995-07-26 Block Drug Co Use of vitamin e in topical pharmaceuticals to enhance penetration of the active agent
JP3202777B2 (ja) * 1992-01-24 2001-08-27 リンテック株式会社 経皮吸収促進剤及びテープ製剤
TW224048B (ko) * 1992-03-30 1994-05-21 Hoechst Roussel Pharma
DE69434199T2 (de) * 1993-10-07 2005-12-29 Odontex, Inc., Lawrence Absorptionsförderer für topische pharmazeutische formulierungen
WO1995022351A1 (fr) * 1994-02-18 1995-08-24 Institute For Advanced Skin Research Inc. Composition pour application locale
US6414028B1 (en) 1997-11-05 2002-07-02 Nexmed Holdings, Inc. Topical compositions containing prostaglandin E1
US6046244A (en) * 1997-11-05 2000-04-04 Nexmed Holdings, Inc. Topical compositions for prostaglandin E1 delivery
US6147102A (en) * 1999-10-26 2000-11-14 Curatek Pharmaceuticals Holding, Inc. Clonidine preparations
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US6638981B2 (en) 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
PT1426049E (pt) * 2002-12-02 2005-09-30 Sanol Arznei Schwarz Gmbh Administracao iontoforetica de rotigotina para o tratamento da doenca de parkinson
CN101146523B (zh) 2004-10-21 2010-12-29 杜雷科特公司 透皮给药系统
US8252319B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
US20060223786A1 (en) * 2005-04-01 2006-10-05 Smith David J Transdermal pain control method and device
US20070248657A1 (en) * 2006-04-25 2007-10-25 Smith David J Multi-compartment transdermal pain control device
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
WO2010036937A1 (en) 2008-09-27 2010-04-01 Taraxos Inc. Topical formulations for treatment of neuropathy
US20100221313A1 (en) * 2008-12-01 2010-09-02 Innovative Pharmaceuticals, Llc Transdermal reservoir patch
EP3999032A4 (en) 2019-07-16 2023-08-30 Donaghys Limited TRANSDERMAL SOLVENT SYSTEM AND METHOD OF USE

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954966A (en) * 1970-06-08 1976-05-04 Ceskoslovenska Akademie Ved Infusion solutions and method of manufacturing same
NL7214924A (ko) * 1971-11-09 1973-05-11
GB1421743A (en) * 1972-04-18 1976-01-21 Wilkinson Sword Ltd Ingestible topical and other compositions
GB1427744A (en) * 1973-05-11 1976-03-10 Whitlock Inc Protective wrapping for an elongate member
DE2947648A1 (de) * 1979-11-27 1981-08-06 C.F. Spiess & Sohn GmbH & Co, 6719 Kleinkarlbach Verwendung tertiaerer heterocyclischer amine als potenzierungsmittel fuer insektizide
DE3009546A1 (de) * 1980-03-13 1981-09-24 Henkel KGaA, 4000 Düsseldorf Desodorierende kosmetische zusammensetzungen
US4590190A (en) * 1983-07-01 1986-05-20 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US4743588A (en) * 1984-06-13 1988-05-10 Allergan Pharmaceuticals, Inc. Compositions and methods of enhancing transdermal and transmembrane penetration systemic agents
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
US4902676A (en) * 1986-09-29 1990-02-20 Nelson Research & Development Co. Compositions comprising N,N-dialkylalkanamides

Also Published As

Publication number Publication date
GR3005442T3 (ko) 1993-05-24
US4808414A (en) 1989-02-28
EP0268220A2 (en) 1988-05-25
JPS63139136A (ja) 1988-06-10
ATE76303T1 (de) 1992-06-15
EP0268220A3 (en) 1988-09-21
EP0268220B1 (en) 1992-05-20
AU8132687A (en) 1988-05-26
AU624573B2 (en) 1992-06-18
ES2042528T3 (es) 1993-12-16
DE3779260D1 (de) 1992-06-25

Similar Documents

Publication Publication Date Title
KR880005945A (ko) 전신 약품의 경피 투여용 침투 증강제
KR880005947A (ko) 전신 약품의 경피 투여용 침투 증강제
CA1306692C (en) Penetration enhancers for transdermal delivery of systemic agents
DE3382616D1 (de) Vermittler des durchdringungsvermoegens zur transdermalen verabreichung systemischer wirkstoffe.
DK602589A (da) Quinazolinonderivater
ES2130247T3 (es) Derivados amidino y su uso como inhibidores de la oxido nitrico sintasa.
NL7504387A (nl) Werkwijze voor de bereiding van een genees- middel met onder meer anti-dermatofytische en anti-bacterien-werking.
DK568187A (da) Transdermal flux-foroegende praeparat
KR910000731A (ko) 4-아미노 3-카르복시 퀴놀린 및 나프티리딘, 그 제조방법 및 그의 의약품으로서 용도
DK93289A (da) Farmaceutiske praeparater med forhoejet transdermal gennemstroemning
DK157482A (da) Galenisk praeparat indeholdende gallopamil eller verapamil og fremgangsmaade til fremstilling heraf
KR880005946A (ko) 전신 약품의 경피 투여용 침투 증강제
FI96856C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoketonijohdannaisten valmistamiseksi
KR880005929A (ko) 전신 약품의 경피 투여용 침투 증강제
KR880004810A (ko) 소화성 궤양 치료제
AR248137A1 (es) Procedimiento para la preparacion de 4-alquil-1, 4-dihidropiridinas con actividad paf-antagonista.
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
ATE19871T1 (de) Derivate von biologisch aktiven phenolverbindungen und diese enthaltende pharmazeutische komposition.
EP0325616A1 (en) PENETRATING AGENTS FOR TRANSDERMAL ADMINISTRATION OF SYSTEMIC AGENTS.
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물
KR890007737A (ko) 진토작용을 하는 약제
TH2745EX (th) ส่วนผสมที่เป็นยาสำหรับควบคุมกำจัดแมลงและสัตว์ในตระกูลอะคาริน่า ซึ่งส่วนผสมนี้มีตัวยาเป็นพวกสาร2-[1-อินโดลินิล-เมทธิล ]-อิมิดาโซลีน หรือเป็นพวกเกลือของสารเหล่านี้
KR890001528A (ko) 성인 t-세포 백혈병/임파종의 억제를 위한 아바론, 아바롤 및 그 유도체의 용도
TH15533A (th) วิธีการบำบัดรักษาการติดเชื้อไวรัส
TH50700A (th) วิธีการและสารผสมสำหรับรักษาความเจ็บปวด

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application